Septerna (SEPN) Return on Capital Employed Growth (1y) (2025 - 2026)

Septerna (SEPN) Return on Capital Employed Growth (1y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Oculis Holding AG 66,861.65 Bn 66,861.36 Bn - 1,648.00
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - -
3 Akari Therapeutics 1,071.19 Bn 1,071.19 Bn - 31,429.00
4 BeOne Medicines 469.11 Bn 464.32 Bn 1.35 Bn 1,805.00
5 Vertex Pharmaceuticals 123.03 Bn 115.78 Bn 2.59 Bn 2,503.00
6 Regeneron Pharmaceuticals 70.13 Bn 61.37 Bn 3.31 Bn -105.00
7 Belite Bio 63.44 Bn 63.44 Bn - -
8 Argenx Se 55.97 Bn 50.78 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.53 Bn 34.52 Bn 959.66 Mn 2,400.00
10 Septerna 1.49 Bn 1.49 Bn - 996.00

Historic Data

Download Data
DateValue
Mar 31, 2026 996.00
Dec 31, 2025 1,344.00